论文信息 - Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer - 字舞流文

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

E. Winer | O. Cohen | N. Lin | G. Shapiro | P. LoRusso | A. D’Andrea | U. Matulonis | J. Geradts | M. Hughes | N. Wagle | S. Wander | S. Isakoff | S. Freeman | S. Tolaney | V. Adalsteinsson | I. Krop | Adrienne G. Waks | Dewey Kim | M. Lloyd | K. Helvie | L. Marini | A. Waks | S. Percy Ivy | B. Kochupurakkal | N. Lin | C. Dunn | J. Buendia Buendia | Connor E. Dunn | Ofir Cohen | Eric P. Winer | Nan Lin | Dae Hyun Kim | J. Buendia | S. P. Ivy | Ursula A. Matulonis